Skip to main content

Table 2 Cox-proportional hazards regression analysis to determine the predictors of PIVC complication among infants admitted in DTCSH, Northwest Ethiopia, 2022

From: Incidence, time to occurrence and predictors of peripheral intravenous cannula-related complications among neonates and infants in Northwest Ethiopia: an institutional-based prospective study

Variables

Out come

AHR (95%CI)

P-value

Complication (%)

Censored (%)

Sex

 Female

64 (55.2%)

52 (44.8%)

1

 

 Male

138 (57%)

104 (43%)

1.68 (0.77–3.65)

0.19

Admission unit

 Pediatric ward

62 (56.9%)

47 (43.1%)

1

 

 NICU

140 (56.2%)

109 (43.8%)

1.88 (1.07–4.02)

0.04*

Anatomical site of cannula insertion

 Scalp

15 (53.6%)

13 (46.4%)

1

 

 Dorsum of hand

118 (51.8%)

110 (48.2%)

1.22 (0.63–2.45)

0.07

 Cubital fossa

22 (61.1%)

14 (38.9%)

2.03 (1.13–6.08)

0.003*

 Leg

47 (71.2%)

19 (28.8%)

2.85 (1.63–6.27)

0.0001*

Admission diagnosis

 Gastrointestinal problem

37 (48.1%)

40 (51.9%)

0.70 (0.45–1.09)

0.12

 Respiratory problem

106 (62.7%)

63 (37.3%)

0.93 (0.65–1.33)

0.71

 Hematologic problem

14 (46.7%)

16 (53.3%)

0.61 (0.33–1.11)

0.11

 Metabolic problem

3 (33.3%)

6 (66.7%)

1.06 (0.33–3.42)

0.92

 Others

42 (57.5%)

31 (42.5%)

1

 

Medication type

 Antibiotics

166 (56.1%)

130 (43.9%)

1

 

 Corticosteroid

11 (47.8%)

12 (52.2%)

2.04 (1.13–3.66)

0.018*

 Others

12 (75%)

4 (25%)

0.77 (0.42–1.43)

0.42

Residency

 Rural

103 (54.5%)

86 (45.5%)

1

0.787

 Urban

99 (58.6%)

70 (41.4%)

1.1 (0.51–2.4)

Flushing

 Yes

170 (58.8%)

119 (41.2%)

0.71 (0.34–0.98)

0.01*

 No

32 (46.4%)

37 (53.6%)

1

Blood transfusion

 Yes

1 (8.3%)

11 (91.7%)

0.79 (0.02–0.99)

0.04*

 No

191 (55.2%)

155 (44.8%)

1

Clinical experience

  ≥ 12 years

11 (57.9%)

8 (42.1%)

0.93 (0.25–3.35)

0.76

 6–11 years

43 (38.4%)

69 (61.6%)

0.52 (0.26–0.84)

0.04*

 3–5 years

146 (66.6%)

73 (33.4%)

0.31 (0.11–0.65)

0.82

  ≤ 2 years

3 (37.5%)

5 (62.5%)

1

 

Sickness

 Acute

189 (58.5%)

134 (41.5%)

2.4 (1.31–4.66)

0.01*

 Chronic

13 (37.1%)

22 (62.9%)

1